Company intelligence / Profile preview

Decorte Future Industries

Oakham, Rutland, England

Ownership: Private
Development stage: Preclinical

Overview

Decorte Future Industries has developed an AI-driven platform that extracts complex biometric health data from body sounds using standard microphones. Their technology enables high-level screening for cardiovascular, respiratory, neurological, and gastrointestinal issues via a smartphone app. Early results have attracted investment from Techstars Ventures and UK government innovation grants. The company’s approach aims to democratize access to preventive healthcare globally.

Therapeutic areas: PulmonologyCardiovascular
Modalities: Device (software-based health screening)Digital health platform
Industry: Digital Health Medical Devices

Partnerships

Techstars London accelerator programUK government innovation grants armLocal organizations in rural India for pilot deployments

Beyond the preview

Go deeper on Decorte Future Industries.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Decorte Future Industries.

Explore the full profile